Cellular cytokine response

The cellular cytokine response is a complex biological process initiated by the binding of cytokines to specific cell-surface receptors, which triggers intracellular signaling cascades—most notably the JAK-STAT pathway—to regulate gene expression (Source: UniProt, 'Cytokine-mediated signaling pathway'). This response is essential for coordinating immune cell recruitment, activation, and differentiation during infection or injury (Source: PubMed, PMID: 30272035). Because it represents a broad physiological pathway rather than a single molecular entity, it is not classified as a discrete therapeutic target; however, its individual components (e.g., TNF-alpha, IL-6, JAK1/2/3) are major targets for anti-inflammatory and immunomodulatory drugs. Dysregulation of the cellular cytokine response is a primary driver of autoimmune diseases such as rheumatoid arthritis and psoriasis, as well as systemic inflammatory conditions like sepsis and cytokine release syndrome (Source: NIH, 'Cytokines and the Immune Response'). Therapeutic intervention typically involves monoclonal antibodies or small molecule inhibitors designed to dampen specific branches of the cytokine network to alleviate chronic inflammation while minimizing the risk of global immunosuppression.

Other names

Cytokine-mediated signaling pathwayCytokine signalingInflammatory cytokine responseCytokine-induced cellular response

Modulation of the cellular cytokine response is achieved through the antagonism of specific cytokines (e.g., TNF-alpha, IL-1), blockade of their respective receptors (e.g., IL-6R), or inhibition of downstream intracellular signaling transducers such as Janus kinases (JAKs).